NEOTHROMITIN(R)

Antigen, Cf, Typhus Fever Group

BEHRING DIAGNOSTICS, INC.

The following data is part of a premarket notification filed by Behring Diagnostics, Inc. with the FDA for Neothromitin(r).

Pre-market Notification Details

Device IDK924395
510k NumberK924395
Device Name:NEOTHROMITIN(R)
ClassificationAntigen, Cf, Typhus Fever Group
Applicant BEHRING DIAGNOSTICS, INC. 17 CHUBB WAY Somerville,  NJ  08876
ContactJoseph Kiceina
CorrespondentJoseph Kiceina
BEHRING DIAGNOSTICS, INC. 17 CHUBB WAY Somerville,  NJ  08876
Product CodeGPO  
CFR Regulation Number866.3500 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1992-08-31
Decision Date1992-12-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.